Skip to main content
. 2021 Jun;42(6):636–642. doi: 10.15537/smj.2021.42.6.20200832

Table 4.

- Frequency and distribution of isoniazid resistance (N=9).

Variables n (%) P-value
Level of resistance
Low (0.1) 7 (77.8) -
High (0.4) 2 (22.2)
Age
1-20 0 0.774
21-40 5 (55.5)
41-60 2 (22.2)
61-90 2 (22.2)
Mean x-bar 42.44
Median 40.00
Standard deviation 19.951
Site of infection
Pulmonary 2 (22.2) 0.400
Extrapulmonary 2 (22.2)
Disseminated 4 (44.4)
Gender
Male 6 (66.6) 0.900
Female 3 (33.3)  
Comorbidities
Diabetes mellitus 2 (22.2) 0.753
Hypertension 3 (33.3) 0.340
Ischemic heart disease 0 0.368
HIV 0 0.758
Malignancy 0 0.402
Immunosuppression 0 0.483
Other comorbidities 3 (33.3) 0.741
No comorbidities 3 (33.3) 0.231

Values are presented as numbers and percentages (%).

HIV: Human immunodeficiency virus